International Stem Cell (ISCO) Operating Margin (QoQ) (2010 - 2025)
Powered by 
Analysis
International Stem Cell (ISCO) Operating Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | International Stem Cell | 3.36 Mn | 2.27 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1,849.00 |
| Sep 30, 2025 | -286.00 |
| Jun 30, 2025 | 1,692.00 |
| Mar 31, 2025 | -1,218.00 |
| Dec 31, 2024 | 622.00 |
| Sep 30, 2024 | -1,052.00 |
| Jun 30, 2024 | 1,475.00 |
| Mar 31, 2024 | 1,409.00 |
| Dec 31, 2023 | -1,753.00 |
| Sep 30, 2023 | 291.00 |
| Jun 30, 2023 | -792.00 |
| Mar 31, 2023 | -241.00 |
| Dec 31, 2022 | 2,013.00 |
| Sep 30, 2022 | -1,915.00 |
| Jun 30, 2022 | 29.00 |
| Mar 31, 2022 | 1,876.00 |
| Dec 31, 2021 | 1,630.00 |
| Sep 30, 2021 | -1,167.00 |
| Jun 30, 2021 | 1,205.00 |
| Mar 31, 2021 | 1,546.00 |